See also this year's filing and all EDGAR filings for this company.
PDF Report 0001638833_2016_Surgery_Partners_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.4610922076609507, 'aggregate_val': 959784000, 'exp_sum': 1780980000, 'exp_to_value': {'LaborExpense': 357175000, 'CostOfGoodsAndServicesSold': 821196000, 'GeneralAndAdministrativeExpense': 60246000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 330689000, 'DepreciationDepletionAndAmortization': 39551000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 172123000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.4598932244965267, 'aggregate_val': 786066000, 'exp_sum': 1455390000, 'exp_to_value': {'LaborExpense': 261685000, 'CostOfGoodsAndServicesSold': 669326000, 'GeneralAndAdministrativeExpense': 55992000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 296210000, 'DepreciationDepletionAndAmortization': 34545000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 137632000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001638833, Surgery Partners Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 1,461,495,000 |
| 1 | AssetsNonCurrent | 8,504,000 |
| 2 | AssetsCurrent | 310,957,000 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 325,728,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 181,314,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 261,685,000 |
| 9 | CostOfGoodsAndServicesSold | 669,326,000 |
| 10 | GeneralAndAdministrativeExpense | 55,992,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 296,210,000 |
| 13 | DepreciationDepletionAndAmortization | 34,545,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -531,692,000 |
| 17 | remainder_Revenues | 959,891,000 |
| 18 | remainder_NetIncome | -100,980,000 |
| 19 | remainder_ComprehensiveNetIncome | -71,416,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,106,684,000 |
| 1 | Liabilities | 181,314,000 |
| 2 | Expenses | 786,066,000 |
| 3 | Revenues | 959,891,000 |
| 4 | StockholdersEquity | 1,925,370,000 |
| 5 | NetIncome | 72,845,000 |
| 6 | ComprehensiveNetIncome | 1,429,000 |
| 7 | BaseVar | 2,103,175,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.44 |
| 9 | EconomicCapitalRatio | 2.69 |